Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Duchesneau

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal of Pediatric Surgery|December 18, 2022
Costs and recurrence of inguinal hernia repair in premature infants during neonatal admissionAlyssa E Peace, Emilie D Duchesneau, Chris B Agala, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 19, 2022
The Timing, the Treatment, the Question: Comparison of Epidemiologic Approaches to Minimize Immortal Time Bias in Real-World Data Using a Surgical Oncology ExampleEmilie D Duchesneau, Bradford E Jackson, Michael Webster-Clark, et al.
Plos One|June 8, 2023
Missing data approaches in longitudinal studies of aging: A case example using the National Health and Aging Trends StudyEmilie D Duchesneau, Shahar Shmuel, Keturah R Faurot, et al.
JCO Clinical Cancer Informatics|February 6, 2024
Functional Status Associations With Treatment Receipt and Outcomes Among Older Adults Newly Diagnosed With Multiple MyelomaChristopher Edward Jensen, Tzy-Mey Kuo, Matthew R LeBlanc, et al.
JAMA Network Open|March 12, 2025
Frailty Trajectories Following Adjuvant Chemotherapy and Mortality in Older Women With Breast CancerEmilie D Duchesneau, Dae Hyun Kim, Til Stürmer, et al.
NPJ Breast Cancer|May 13, 2022
Pathologic complete response and survival after neoadjuvant chemotherapy in cT1-T2/N0 HER2+ breast cancerSelena J An, Emilie D Duchesneau, Paula D Strassle, et al.
Annals of Surgical Oncology|January 18, 2022
Sociodemographic and Clinical Predictors of Neoadjuvant Chemotherapy in cT1-T2/N0 HER2-Amplified Breast CancerEmilie D Duchesneau, Selena J An, Paula D Strassle, et al.
Medical Care|January 20, 2026
Differences in the Measurement of Comorbidities Based on ICD-10-CM Coding Definitions Using Medicare Advantage Encounter Data and Fee-For-Service ClaimsEmilie D Duchesneau, Allison Musty, Elyse Miller, et al.
American Journal of Epidemiology|July 11, 2023
Translation of a Claims-Based Frailty Index From the International Classification of Diseases, Ninth Revision, Clinical Modification to the Tenth RevisionEmilie D Duchesneau, Shahar Shmuel, Keturah R Faurot, et al.
Annals of Vascular Surgery|May 23, 2022
Gender Disparities in Aortoiliac Revascularization in Patients with Aortoiliac Occlusive DiseaseAustin J Allen, Devin Russell, Megan E Lombardi, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of Pediatric Surgery|December 18, 2022
Costs and recurrence of inguinal hernia repair in premature infants during neonatal admissionAlyssa E Peace, Emilie D Duchesneau, Chris B Agala, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 19, 2022
The Timing, the Treatment, the Question: Comparison of Epidemiologic Approaches to Minimize Immortal Time Bias in Real-World Data Using a Surgical Oncology ExampleEmilie D Duchesneau, Bradford E Jackson, Michael Webster-Clark, et al.
Plos One|June 8, 2023
Missing data approaches in longitudinal studies of aging: A case example using the National Health and Aging Trends StudyEmilie D Duchesneau, Shahar Shmuel, Keturah R Faurot, et al.
JCO Clinical Cancer Informatics|February 6, 2024
Functional Status Associations With Treatment Receipt and Outcomes Among Older Adults Newly Diagnosed With Multiple MyelomaChristopher Edward Jensen, Tzy-Mey Kuo, Matthew R LeBlanc, et al.
JAMA Network Open|March 12, 2025
Frailty Trajectories Following Adjuvant Chemotherapy and Mortality in Older Women With Breast CancerEmilie D Duchesneau, Dae Hyun Kim, Til Stürmer, et al.
NPJ Breast Cancer|May 13, 2022
Pathologic complete response and survival after neoadjuvant chemotherapy in cT1-T2/N0 HER2+ breast cancerSelena J An, Emilie D Duchesneau, Paula D Strassle, et al.
Annals of Surgical Oncology|January 18, 2022
Sociodemographic and Clinical Predictors of Neoadjuvant Chemotherapy in cT1-T2/N0 HER2-Amplified Breast CancerEmilie D Duchesneau, Selena J An, Paula D Strassle, et al.
Medical Care|January 20, 2026
Differences in the Measurement of Comorbidities Based on ICD-10-CM Coding Definitions Using Medicare Advantage Encounter Data and Fee-For-Service ClaimsEmilie D Duchesneau, Allison Musty, Elyse Miller, et al.
American Journal of Epidemiology|July 11, 2023
Translation of a Claims-Based Frailty Index From the International Classification of Diseases, Ninth Revision, Clinical Modification to the Tenth RevisionEmilie D Duchesneau, Shahar Shmuel, Keturah R Faurot, et al.
Annals of Vascular Surgery|May 23, 2022
Gender Disparities in Aortoiliac Revascularization in Patients with Aortoiliac Occlusive DiseaseAustin J Allen, Devin Russell, Megan E Lombardi, et al.
Pageof 4